(Reuters) - Corteva (NYSE:CTVA) Inc will buy biologicals firm Stoller Group Inc for $1.2 billion in cash, the companies said on Wednesday, as it looks to expand its crop protection business.
Biologicals related to the agriculture sector are a growing market and expected to represent about 25% of the overall crop protection market by 2035.
Corteva has been working toward enhancing its portfolio of crop protection assets and bought Spain-based Symborg in September.
The Stoller deal, which is expected to close in the first half of 2023, will be accretive to Corteva's core earnings in 2023, the companies said.